呼吸器外科

Keyphrases

1. Lung Adenocarcinoma 100%
2. Adipose-derived MSCs 100%
3. Lung Adenocarcinoma Subtypes 83%
4. Pathologist 75%
5. Non-small Cell Lung Cancer (NSCLC) 60%
6. Interobserver Variability 58%
7. Rat Lung 56%
8. Internal Cavity 50%
9. Stent Simulation 50%
10. Consumer-grade 50%
11. Deep Learning 50%
12. Standardized Classification 50%
13. Grade Estimation 50%
14. Downstream Applications 50%
15. Clustering Approach 50%
16. New Targets 50%
17. Vessel Invasion 50%
18. Poor Prognostic Factors 50%
19. Adjuvant Chemotherapy 50%
20. Bio 3D Printing 50%
21. Scaffold-free 50%
22. Human Cells 50%
23. Free-form Structures 50%
24. 3D Printing System 50%
25. Rat Trachea 50%
26. Trachea 50%
27. Lung Epithelial Cells 50%
28. Anticancer Agents 50%
29. Mesenchymal Stromal Cells 50%
30. Lung Transplantation 50%
31. Adipokinetic Hormone 50%
32. Nude Mouse Model 50%
33. Malignant Pleural Mesothelioma 50%
34. Mesenchymal Stem Cell Therapy 50%
35. Malignant Mesothelioma 50%
36. Barrier Function 50%
37. Adipose-derived Mesenchymal Stem Cells (ADMSCs) 50%
38. Radiosensitivity 50%
39. Antioxidant System 50%
40. Pro-oxidant 50%
41. Critically Ill Patients 50%
42. Phase II Study 50%
43. Pain Research 50%
44. Odontogenic Infection 50%
45. Postoperative Air Leak 50%
46. Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) 50%
47. Air Leak 50%
48. Induction Chemoradiotherapy 50%
49. Mirogabalin 50%
50. Concurrent Chemoradiotherapy 50%
51. Peripheral Neuropathic Pain 50%
52. Chest Wall 50%
53. Living-donor Lobar Lung Transplantation (LDLLT) 50%
54. Conventional Therapy 50%
55. Thoracic Surgery 50%
56. Cisplatin 50%
57. Pulmonary Alveolar Proteinosis 50%
58. Surgical Learning 50%
59. Neuropathic Pain 50%
60. Lymphoid Follicular Hyperplasia 50%
61. Descending Necrotizing Mediastinitis 50%
62. Autologous Blood 50%
63. Pleurodesis 50%
64. Predictive Factors 50%
65. Retrospective Cohort Study 50%
66. Hepatectomy 50%
67. Surgical Site Infection 50%
68. Thymidine Synthase 50%
69. Reactive Oxidant Species 40%
70. Biological Antioxidant Potential 40%
71. Irradiation 37%
72. Surgical Resection 36%
73. Pulmonary Resection 35%
74. Lung 34%
75. Modified Ratio 30%
76. Non-survivors 30%
77. Oxidative Stress 30%
78. Complex Segmentectomy 28%
79. Multiple Dose 28%
80. Training Model 25%
81. Radiosensitizing Effect 25%
82. Total-body 25%
83. Thoracic Cavity 20%
84. Tumor 20%
85. Deep Surgical Site Infection 20%
86. Survivors 20%
87. Acute Phase 20%
88. Adverse Reactions 20%
89. Oral Fluoropyrimidine 20%
90. Transplantation 20%
91. Surgical Drainage 20%
92. Granulocyte Colony-stimulating Factor (G-CSF) 20%
93. Conventional Treatment 20%
94. Lobar Lung Transplantation 20%
95. Scaffold-based 18%
96. Immunostaining 18%
97. Older Women 18%
98. Histopathological Images 16%

Medicine and Dentistry

1. Lung Adenocarcinoma 100%
2. Non Small Cell Lung Cancer 100%
3. Lung Transplantation 100%
4. Neoplasm 65%
5. Surgeon 58%
6. Pathologist 57%
7. Thoracic Wall 57%
8. Retrospective Cohort Study 54%
9. Stenting 50%
10. Adjuvant Chemotherapy 50%
11. Prognostic Factor 50%
12. Mesothelioma 50%
13. Pleura Mesothelioma 50%
14. Adipose Tissue 50%
15. Mesenchymal Stem Cell Transplantation 50%
16. Anticarcinogen 50%
17. Adipose-Derived Mesenchymal Stem Cell 50%
18. Radiosensitivity 50%
19. Lymphoid Hyperplasia 50%
20. Predictive Factor 50%
21. Learning Curve 50%
22. Neuropathic Pain 50%
23. Odontogenic Infection 50%
24. Mirogabalin 50%
25. Lung Alveolus Proteinosis 50%
26. Cisplatin 50%
27. Thorax Surgery 50%
28. Living Donors 50%
29. Video-Assisted Thoracoscopic Surgery 50%
30. Chemoradiotherapy 50%
31. Segmentectomy 50%
32. Mediastinitis 50%
33. Pleurodesis 50%
34. Hepatectomy 50%
35. Surgical Infection 50%
36. Lung 37%
37. Pneumonectomy 35%
38. Stenosis 33%
39. Stent Placement 33%
40. Surgery 30%
41. Computer Assisted Tomography 25%
42. Infection 25%
43. Adverse Event 24%
44. Recurrent Disease 24%
45. Diagnosis 22%
46. Survival Rate 21%
47. Multiple Drug Dose 21%
48. Thoracic Cavity 20%
49. Immunosuppressive Drug 20%
50. Granulocyte Macrophage Colony Stimulating Factor 20%
51. Radiation Therapy 19%
52. Immunohistochemistry 17%
53. Health Care Cost 16%
54. Surgical Drainage 16%
55. Hemodialysis 16%
56. Lymphoproliferative Disease 16%
57. Visual Analog Scale 15%
58. Treatment Group 15%
59. UFT 14%
60. Chemotherapy 14%
61. Single Drug Dose 14%
62. Thrombin 14%
63. Combination Therapy 14%
64. Asbestos Exposure 12%
65. Mesothelioma Cell Line 12%
66. Cell Proliferation 12%
67. Tumor Progression 12%
68. Disease 12%
69. Prostate Cancer Cell Line 12%
70. Back 12%
71. Programmed Cell Death 12%
72. Xenograft 12%
73. Protein Expression 12%
74. Hypoxia Inducible Factor 1 12%
75. Vascular Tissue Neoplasm 12%
76. Radiosensitizer 12%
77. Lung Cancer Cell Line 12%
78. Messenger RNA 12%
79. Disease Specific Survival 10%
80. Mesenchymal Stem Cell 10%
81. Organ Transplantation 10%
82. Tacrolimus 10%
83. Immunosuppressive Treatment 10%
84. Quality of Life 10%
85. Lung Lavage 10%
86. Oxygen Therapy 10%
87. Inhalational Drug Administration 10%
88. Autoantibodies 10%
89. Physical Disease by Body Function 10%
90. Chronic Pain 10%
91. Propensity Score Matching 9%
92. Aortic Valve Replacement 8%
93. Trismus 8%
94. Glomerulonephritis 8%
95. Angiofollicular Lymph Node Hyperplasia 8%
96. Drainage Procedure 8%
97. Benign Tumor 8%
98. Cancer 8%
99. Mandibular Molar 8%
100. Neck 8%